• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质细胞来源因子 1 通过激活 PI3K-AKT 信号通路促进胆管癌细胞的恶性表型。

Activation of the PI3K-AKT signaling pathway by SPARC contributes to the malignant phenotype of cholangiocarcinoma cells.

机构信息

Medical School, Kunming University of Science and Technology, Kumming, Yunnan, China; Department of Hepatobiliary and Pancreatic Surgery, The First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kumming, Yunnan, China.

Department of Hepatobiliary and Pancreatic Surgery, The First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kumming, Yunnan, China.

出版信息

Tissue Cell. 2022 Jun;76:101756. doi: 10.1016/j.tice.2022.101756. Epub 2022 Feb 10.

DOI:10.1016/j.tice.2022.101756
PMID:35217388
Abstract

Cholangiocarcinoma (CCA) is a primary biliary epithelium malignancy with limited therapies, poor prognosis and high mortality rate. Nowadays, the molecular mechanisms of CCA remain elusive. SPARC has been proposed to be highly expressed in clinical CCA tissues, but few studies has been elucidated its functions in CCA. In the current study, we aimed to investigate the functional role of SPARC in the progression of CCA. In this study, a significantly increased expression of SPARC was observed in CCA tissues and cells. Knockdown of SPARC by RNA interference significantly impeded the proliferation of CCA cells. Moreover, SPARC silencing hampered the migration and invasion of CCA cells by inhibiting EMT. In parallel, overexpression of SPARC in RBE cells had the opposite effects. Mechanically, SPARC promoted proliferation, migration, invasion, and EMT of CCA cells in vitro via activating the PI3K-AKT signaling. Overall, our integrated analysis revealed that SPARC plays a crucial role in CCA progression via the PI3K-AKT signaling pathway, which suggests that targeting SPARC might represent a promising approach for improving CCA patient's clinical outcome.

摘要

胆管癌(CCA)是一种原发性胆道上皮恶性肿瘤,治疗方法有限,预后差,死亡率高。目前,CCA 的分子机制仍不清楚。已有研究提出,富含半胱氨酸的酸性分泌蛋白(SPARC)在临床 CCA 组织中高表达,但对其在 CCA 中的功能研究甚少。本研究旨在探讨 SPARC 在 CCA 进展中的功能作用。本研究观察到 SPARC 在 CCA 组织和细胞中表达明显增加。RNA 干扰敲低 SPARC 显著抑制 CCA 细胞的增殖。此外,通过抑制 EMT,SPARC 沉默抑制了 CCA 细胞的迁移和侵袭。同时,在 RBE 细胞中过表达 SPARC 则产生了相反的效果。机制上,SPARC 通过激活 PI3K-AKT 信号通路促进 CCA 细胞的体外增殖、迁移、侵袭和 EMT。综上所述,我们的综合分析表明,SPARC 通过 PI3K-AKT 信号通路在 CCA 进展中发挥关键作用,提示靶向 SPARC 可能是改善 CCA 患者临床预后的一种有前途的方法。

相似文献

1
Activation of the PI3K-AKT signaling pathway by SPARC contributes to the malignant phenotype of cholangiocarcinoma cells.基质细胞来源因子 1 通过激活 PI3K-AKT 信号通路促进胆管癌细胞的恶性表型。
Tissue Cell. 2022 Jun;76:101756. doi: 10.1016/j.tice.2022.101756. Epub 2022 Feb 10.
2
Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.三结构域蛋白 59(TRIM59)的敲低通过 PI3K/AKT/mTOR 信号通路抑制胆管癌细胞的增殖。
Gene. 2019 May 25;698:50-60. doi: 10.1016/j.gene.2019.02.044. Epub 2019 Feb 27.
3
SPARC induces M2 polarization of macrophages to promote proliferation, migration, and angiogenesis of cholangiocarcinoma cells.基质细胞关联基因 2(SPARC)可诱导巨噬细胞向 M2 型极化,从而促进胆管癌细胞的增殖、迁移和血管生成。
Neoplasma. 2022 Sep;69(5):1101-1107. doi: 10.4149/neo_2022_220324N333. Epub 2022 Aug 12.
4
Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression.针对双皮质素样激酶 1 高表达的胆管癌患者,靶向 PI3K/AKT/mTOR 通路提供了一种有前景的治疗策略。
J Cancer Res Clin Oncol. 2024 Jul 9;150(7):342. doi: 10.1007/s00432-024-05875-3.
5
ARHGAP21 Is Involved in the Carcinogenic Mechanism of Cholangiocarcinoma: A Study Based on Bioinformatic Analyses and Experimental Validation.ARHGAP21 参与胆管癌的致癌机制:基于生物信息学分析和实验验证的研究。
Medicina (Kaunas). 2023 Jan 10;59(1):139. doi: 10.3390/medicina59010139.
6
Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway.通过抑制 PTEN/PI3K/Akt 通路,雷公藤红素抑制胆管癌细胞增殖、侵袭和迁移从而发挥抗肿瘤活性。
Cancer Med. 2020 Jan;9(2):783-796. doi: 10.1002/cam4.2719. Epub 2019 Nov 26.
7
Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma.衔接蛋白 XB130 调控胆管癌的侵袭性。
PLoS One. 2021 Nov 15;16(11):e0259075. doi: 10.1371/journal.pone.0259075. eCollection 2021.
8
Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.PI3K/AKT信号通路的激活增加与胆管癌转移相关,PI3K/mTOR抑制是一种可能的治疗策略。
Tumour Biol. 2013 Dec;34(6):3637-48. doi: 10.1007/s13277-013-0945-2. Epub 2013 Jul 6.
9
miR-181b-5p Promotes the Progression of Cholangiocarcinoma by Targeting PARK2 via PTEN/PI3K/AKT Signaling Pathway.miR-181b-5p 通过靶向 PARK2 经 PTEN/PI3K/AKT 信号通路促进胆管癌的进展。
Biochem Genet. 2022 Feb;60(1):223-240. doi: 10.1007/s10528-021-10084-5. Epub 2021 Jun 24.
10
A PLCB1-PI3K-AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression.PLCB1-PI3K-AKT 信号轴激活 EMT 促进胆管癌进展。
Cancer Res. 2021 Dec 1;81(23):5889-5903. doi: 10.1158/0008-5472.CAN-21-1538. Epub 2021 Sep 27.

引用本文的文献

1
Methyl-CpG binding domain protein 2 (Mbd2) drives breast cancer progression through the modulation of epithelial-to-mesenchymal transition.甲基化 CpG 结合域蛋白 2(Mbd2)通过调节上皮间质转化促进乳腺癌进展。
Exp Mol Med. 2024 Apr;56(4):959-974. doi: 10.1038/s12276-024-01205-2. Epub 2024 Apr 1.
2
DHW-208, A Novel Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Has Anti-Hepatocellular Carcinoma Activity Through Promoting Apoptosis and Inhibiting Angiogenesis.新型磷脂酰肌醇3激酶(PI3K)抑制剂DHW-208通过促进凋亡和抑制血管生成发挥抗肝细胞癌活性。
Front Oncol. 2022 Jul 12;12:955729. doi: 10.3389/fonc.2022.955729. eCollection 2022.
3
Targeting Src-Hic-5 Signal Cascade for Preventing Migration of Cholangiocarcinoma Cell HuCCT1.
靶向Src-Hic-5信号级联以预防胆管癌细胞HuCCT1的迁移
Biomedicines. 2022 Apr 28;10(5):1022. doi: 10.3390/biomedicines10051022.